Table 1.
Clinical characteristics and levels of serum lipids in healthy subjects, celiac patients at diagnosis (CD patients) and celiac patients treated with a gluten-free diet (GFD patients). Data are given as means ± S.D.
| Healthy subjects (n = 25) | Celiac patients (n = 27) | ||
|---|---|---|---|
| CD patients(n = 11) | GFD patients (n = 16) | ||
| Serum t-TGa (U/mL) | 0.4 ± 0.2 | 108.2 ± 35.9* | 2.3 ± 1.9∗# |
| Damage of intestinal mucosab | 0 | 4.4 ± 0.6* | 1.4 ± 0.7∗# |
| Serum triglycerides (mg/dL) | 87.140.5± | 61.3 ± 23.5 | 71.2 ± 48.2 |
| Serum cholesterol (mg/dL) | 186.6 ± 43.4 | 154.1 ± 27.6 | 177.1 ± 42.6 |
| Serum HDL-cholesterol (mg/dL) | 56.3 ± 13.4 | 51.1 ± 7.9 | 54.6 ± 8.7 |
| Serum LDL-cholesterol (mg/dL) | 113.2 ± 23.7 | 90.6 ± 16.1 | 108.8 ± 26.2 |
at-TG: antitransglutaminaseantibodies. bDamage of intestinal mucosa was classified according to Marsh parameters and each stage was given a score from 0 (normal mucosa) to 5 (total villous atrophy).
∗ P < 0.001 versus healthy subjects; # P < 0.05 versus CD patients.